Drugs / CoTIL-01
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04389229 | Jul 2020 → Mar 2023 | ovarian cancer | Immetacyte Ltd | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CoTIL-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04389229 ↗ |
| Modality | Cell therapy | “gene modified (CoTIL-01) adoptive TIL therapy” NCT04389229 ↗ |